Nakul Raval
Has grant
Associate Research Scientist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Novel GluN2BR Radioligand for PET Neuroimaging in Alcohol Use Disorder
Open Date: 2025-09-05
Close Date: 2027-08-31
Articles (15)
Tobacco smoking, a major cause of preventable mortality, upregulates β2 subunit-containing nicotinic acetylcholine receptors (β2*-nAChR) in most brain regions. Although the α4 subunit most frequently co-assembles with β2, other subunits likely assemble with β2 and contribute to distinct aspects of nicotine-mediated behaviors, but these factors are poorly understood in people. This work performed independent component analysis (ICA) of [ 18 F]Flubatine positron emission tomography (PET) image data to identify maximally independent sources of specific binding to β2*-nAChRs. We then compared their magnitudes (loading coefficients) in people who recently stopped smoking cigarettes (abstinent smokers; n = 26) and people who never smoked cigarettes (non-smokers; n = 20). ICA identified 3 reproducible components: IC1 (36% of variance) in medial thalamus, lateral thalamus, and red nucleus; IC2 (18% of variance) in ventral thalamus, lateral geniculate, and midbrain; IC3 (19% of variance) in cerebellum and optic circuitry in midbrain. Nicotine challenge in an independent sample ( n = 9) reduced loading coefficients of all components, confirming specific binding to nAChRs. Post-mortem autoradiography of cerebellum showed greatest [ 18 F]Flubatine displacement by α3/α6β2*-nAChR blocker (α-Conotoxin MII) but low displacement by α6β2*-nAChR blocker (α-Conotoxin PIA), suggesting that IC3 measures α3β2*-nAChRs specific binding – a novel finding in living people. Loading coefficients of IC1 and IC2 were significantly lower in abstinent smokers compared to non-smokers. IC3 loading coefficients were significantly higher during extended smoking abstinence, and exploratory analyses suggested initial evidence for daily smoking amount correlating with nicotine dependence severity. These results could inform novel treatment development to help people quit smoking.
Year:
2026
Background Alcohol consumption at clinically relevant doses alters brain glutamate release. However, few techniques exist to measure these changes in humans. The metabotropic glutamate receptor 5 (mGluR5) PET radioligand [ 11 C]ABP688 is sensitive to acute alcohol in rodents, possibly mediated by alcohol effects on glutamate release. This study aimed to determine the sensitivity of [ 11 C]ABP688 PET to an acute alcohol challenge in humans. Methods Eight social drinkers (25–42 years; 5 females) with a recent drinking occasion achieving a blood alcohol level (BAL) > 80 mg/dL were recruited. All participants underwent a 90‐min dynamic baseline [ 11 C]ABP688 PET scan. Two weeks later (range: 7–29 days), participants completed an oral laboratory alcohol challenge over 30 min, targeting a BAL of 60 mg/dL. Immediately after the challenge, a second [ 11 C]ABP688 PET scan was performed. Non‐displaceable binding potential ( BP ND ; indicative of mGluR5 availability) and R 1 (indicative of relative blood flow) were estimated using the simplified reference tissue model with the cerebellum as the reference region. Blood samples were taken throughout the scanning procedure to measure the BAL. Results Seven participants (4 females) completed the study. The mean peak BAL achieved was 61 ± 18 mg/dL. Acute alcohol significantly decreased [ 11 C]ABP688 BP ND , F (1, 42) = 17.05, p < 0.001, Cohen's d = 0.32–0.60, and increased [ 11 C]ABP688 R 1 , F (1, 42) = 6.67, p = 0.013, Cohen's d = 0.32–0.48, across brain regions. Exploratory analysis showed a positive relationship between alcohol‐induced % change in [ 11 C]ABP688 R 1 in cortical regions and peak BAL (Spearman rho = 0.78 [frontal cortex] and 0.85 [temporal cortex] = 0.024 and 0.011). Conclusions This proof‐of‐concept study demonstrates that [ 11 C]ABP688 PET imaging is sensitive to the effects of acute alcohol consumption. The observed decrease in mGluR5 availability aligns with preclinical data potentially indicating acute increased extracellular glutamate concentrations following ethanol dosing. This imaging tool could be useful for future investigations into the acute effects of alcohol on the brain during abstinence and withdrawal.
Year:
2025
Background There is no safe amount or time of alcohol consumption during pregnancy; however, many women drink while pregnant placing themselves and their fetuses at risk for alcohol-related health complications. Social Determinants of Health (SDoH) impact alcohol use during pregnancy. Understanding the impact of SDoH across pregnancy will elucidate important information to reduce rates of prenatal alcohol exposure. Methods Cross-sectional data from the National Survey of Drug Use and Health from 2009 to 2019 was used to explore the impact of SDoH on alcohol use across pregnancy. The study assesses past month alcohol use and past month binge drinking, as well as various SDoH. The sample included 8,638 pregnant women. Results Over 9% of pregnant women reported alcohol use within the past 30 days and 5.25% reported drinking on three or more days within the past month. 3.65% reported past month binge drinking. Past month alcohol use and past month binge drinking decreased in the second and third trimesters; however, a subset of women continued alcohol use, including binge drinking. Specific SDoH emerged as increasing the likelihood of alcohol use within the past month, including not being married (ORs = 1.54 to 1.94), criminal justice involvement (arrested and booked; OR = 1.88), and past year psychiatric distress (OR = 1.86). Conversely, other determinants were associated with a lower likelihood of alcohol use, including identifying as Asian or Hispanic (ORs = 0.41 and 0.64) and unemployment (OR = 0.52) and other employment (OR = 0.66). Older age was associated with a lower likelihood of binge drinking within the past month (ORs = 0.32). Unique SDoH emerged when examining alcohol use by trimester. Conclusion Specific SDoH (i.e., not married, criminal justice involvement, past year psychiatric distress) are related to increased alcohol use during pregnancy, while other determinants (i.e., identifying as Asian or Hispanic, not requiring full time/part-time employment) are associated with a decreased risk for past month alcohol use. Older individuals (35–49 years old) and those with a high school education had a decreased likelihood of binge drinking. Accordingly, healthcare providers should screen all pregnant women for alcohol use throughout pregnancy, especially among populations or groups identified as being vulnerable to continue alcohol use during pregnancy.
Year:
2025
Year:
2025
Year:
2024
Synapses are fundamental to the function of the central nervous system and are implicated in a number of brain disorders. Despite their pivotal role, a comprehensive imaging resource detailing the distribution of synapses in the human brain has been lacking until now. Here, we employ high-resolution PET neuroimaging in healthy humans (17F/16M) to create a 3D atlas of the synaptic marker Synaptic Vesicle glycoprotein 2A (SV2A). Calibration to absolute density values (pmol/ml) was achieved by leveraging postmortem human brain autoradiography data. The atlas unveils distinctive cortical and subcortical gradients of synapse density that reflect functional topography and hierarchical order from core sensory to higher-order integrative areas—a distribution that diverges from SV2A mRNA patterns. Furthermore, we found a positive association between IQ and SV2A density in several higher-order cortical areas. This new resource will help advance our understanding of brain physiology and the pathogenesis of brain disorders, serving as a pivotal tool for future neuroscience research.
Year:
2024
Year:
2024
Synaptic loss is a primary pathology in Alzheimer’s disease and correlates best with cognitive impairment as found in post-mortem studies. Previously, we observed in vivo reductions of synaptic density with [11C]UCB-J PET (radiotracer for synaptic vesicle protein 2A) throughout the neocortex and medial temporal brain regions in early Alzheimer’s disease. In this study, we applied independent component analysis to synaptic vesicle protein 2A-PET data to identify brain networks associated with cognitive deficits in Alzheimer’s disease in a blinded data-driven manner. [11C]UCB-J binding to synaptic vesicle protein 2A was measured in 38 Alzheimer’s disease (24 mild Alzheimer’s disease dementia and 14 mild cognitive impairment) and 19 cognitively normal participants. [11C]UCB-J distribution volume ratio values were calculated with a whole cerebellum reference region. Principal components analysis was first used to extract 18 independent components to which independent component analysis was then applied. Subject loading weights per pattern were compared between groups using Kruskal–Wallis tests. Spearman’s rank correlations were used to assess relationships between loading weights and measures of cognitive and functional performance: Logical Memory II, Rey Auditory Verbal Learning Test—long delay, Clinical Dementia Rating sum of boxes and Mini-Mental State Examination. We observed significant differences in loading weights among cognitively normal, mild cognitive impairment and mild Alzheimer’s disease dementia groups in 5 of the 18 independent components, as determined by Kruskal–Wallis tests. Only Patterns 1 and 2 demonstrated significant differences in group loading weights after correction for multiple comparisons. Excluding the cognitively normal group, we observed significant correlations between the loading weights for Pattern 1 (left temporal cortex and the cingulate gyrus) and Clinical Dementia Rating sum of boxes (r = −0.54, P = 0.0019), Mini-Mental State Examination (r = 0.48, P = 0.0055) and Logical Memory II score (r = 0.44, P = 0.013). For Pattern 2 (temporal cortices), significant associations were demonstrated between its loading weights and Logical Memory II score (r = 0.34, P = 0.0384). Following false discovery rate correction, only the relationship between the Pattern 1 loading weights with Clinical Dementia Rating sum of boxes (r = −0.54, P = 0.0019) and Mini-Mental State Examination (r = 0.48, P = 0.0055) remained statistically significant. We demonstrated that independent component analysis could define coherent spatial patterns of synaptic density. Furthermore, commonly used measures of cognitive performance correlated significantly with loading weights for two patterns within only the mild cognitive impairment/mild Alzheimer’s disease dementia group. This study leverages data-centric approaches to augment the conventional region-of-interest–based methods, revealing distinct patterns that differentiate between mild cognitive impairment and mild Alzheimer’s disease dementia, marking a significant advancement in the field.
Year:
2024
Background: Alcohol consumption at clinically relevant doses alters brain glutamate release. However, few techniques exist to measure these changes in humans. The metabotropic glutamate receptor 5 (mGluR5) PET radioligand [ 11 C]ABP688 is sensitive to acute alcohol in rodents, possibly mediated by alcohol effects on glutamate release. This study aimed to determine the sensitivity of [ 11 C]ABP688 PET to an acute alcohol challenge in humans. Methods: Eight social drinkers (25–42 years; 5 females) with a recent drinking occasion achieving blood alcohol level (BAL)>80 mg/dL were recruited. All participants underwent a 90-minute dynamic baseline [ 11 C]ABP688 PET scan. Two weeks later (range: 7-29 days), participants completed an oral laboratory alcohol challenge over 30 minutes, targeting a BAL of 60 mg/dL. Immediately after the challenge, a second [ 11 C]ABP688 PET scan was performed. Non-displaceable binding potential ( BP ND ; indicative of mGluR5 availability) and R 1 (indicative of relative blood flow) were estimated using the Simplified Reference Tissue Model with the cerebellum as the reference region. Blood samples were taken throughout the scanning procedure to measure the BAL. Results: Seven participants (4 females) completed the study. The mean peak BAL achieved was 61 ± 18 mg/dL. Acute alcohol significantly decreased [ 11 C]ABP688 BP ND (F(1,42) = 17.05, p < 0.001; Cohen’s d = 0.32–0.60) and increased [ 11 C]ABP688 R 1 (F(1,42) = 6.67, p = 0.013; Cohen’s d = 0.32–0.48) across brain regions. Exploratory analysis showed a positive relationship between alcohol-induced % change in [ 11 C]ABP688 R 1 in cortical regions and peak BAL (Spearman rho = 0.78 & 0.85; p = 0.024 & 0.011). Conclusions: This proof-of-concept study demonstrates that [ 11 C]ABP688 PET imaging is sensitive to the effects of acute alcohol consumption. The observed decrease in mGluR5 availability aligns with preclinical data indicating acute increased extracellular glutamate concentrations following ethanol dosing. This imaging tool could be useful for future investigations into the acute effects of alcohol on the brain during abstinence and withdrawal.
Year:
2024
Parkinson’s disease is a neurodegenerative disease, which is associated with accumulation of α-synuclein protein aggregates and Lewy Body formation. These neurotoxic inclusions are especially harmful for dopamine-producing neurons in the substantia nigra of the brain. The cellular degradation system autophagy can reduce neurotoxicity caused by accumulated α-synuclein, by targeting it for degradation. Previously, we demonstrated that human TBC1D15 inhibits autophagy in vitro , resulting in accumulation of neurotoxic protein aggregates. Conversely, lowering the TBC1D15 expression promotes autophagy and degradation of α-synuclein and huntingtin proteins in various cell models. Here we show that knockdown of murine Tbc1d15 in vivo activates autophagy, reduces α-synuclein-mediated neurotoxicity, and improves motor performance. Thus, targeting Tbc1d15 expression may be a therapeutic avenue for neurodegenerative diseases.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (19)
Patrick Ejlerskov
Senior Scientist
Rigshospitalet
Vincent Beliveau
Head of Data Infrastructure, Human Genome Austria
Medical University of Innsbruck
Eduardo Felipe Alves Fernandes
Københavns Universitet
Hannes Mikula
TU Wien
Roger Pocock
Professor
MONASH UNIVERSITY
Betina Elfving
VIP, Associate Professor
Aarhus University
Gitte Moos Knudsen
Center director
Rigshospitalet
Marina Picciotto
Yale University
David C. Rubinsztein
University of Cambridge
Yiyun Huang
Professor
Yale University
Vladimir Shalgunov
Københavns Universitet
Mikael Palner
Associate Professor
Odense Universitetshospital
Yuki Mori
Københavns Universitet
David Matuskey
Yale University
Vibeke Høyrup Dam
Københavns Universitet
Nabeel Nabulsi
• Assistant Professor of Clinical Radiochemistry, Chief Radiochemist
Columbia University Irving Medical Center
Kristian Strømgaard
Professor, Director
Københavns Universitet
Susana Aznar
Head of Research
Bispebjerg Hospital
Vince Calhoun
Distinguished University Professor and Director Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS)
Emory University
Make your next move.
Prepare your application
Review drafts before you send them.